News | Conference Coverage | April 20, 2022

ASPC Announces Official Program at Premier Annual Congress on CVD Prevention

The program covers the "ABCs of Preventive Cardiology" over the 2.5 day live, in-person program

The American Society for Preventive Cardiology (ASPC) announces the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, KY.

Pamela S. Douglas, MD, MACC, FASPC


April 20, 2022 – The American Society for Preventive Cardiology (ASPC) announces the official program for the ASPC 2022 Congress on CVD Prevention, scheduled July 29-31, 2022 in Louisville, KY. The program covers the "ABCs of Preventive Cardiology" over the 2.5 day live, in-person program, and can be found on aspconline.org/2022congress.

Included in the 2022 program are a variety of distinguished award lectures including the notable Honorary Fellowship Award and Lecture, honoring Pamela S. Douglas, MD, MACC, FASPC, for her incredible contributions to the field of preventive cardiology. Dr. Douglas will be presenting her lecture entitled "Strengthening CV Prevention for the Future: Beyond the ABCs" on Friday, July 29th during the opening session of the 2022 Congress.

Douglas is the Ursula Geller Professor of Research in Cardiovascular Diseases in the Department of Medicine at Duke University. She has led several landmark multicenter randomized clinical trials and outcomes research studies and is renowned for her scientific and policy work in improving the quality and appropriateness of imaging in clinical care, clinical trials, and registries. Dr Douglas helped to establish several important specialty areas including heart disease in women, sports cardiology, and cardio-oncology.

Other distinguished lecturers, include:

Scott Grundy, MD, PhD will be honored with the Pioneer in Prevention Award on Saturday, July 30th, presenting a lecture on "National Cholesterol Guidelines: 1987-2018". The Pioneer in Prevention Award (previously named Leaders in Medicine) is bestowed on individuals who have profoundly impacted cardiovascular disease prevention by taking the field in a whole new direction.

Also on Saturday, July 30th, Carl J. Pepine, MD, MACC will be honored with the Nanette Wenger Award presenting a lecture on "Open Artery Ischemia: An Unrecognized Opportunity for Prevention?". Dr. Pepine is a Professor and Chief of Cardiovascular Medicine at the University of Florida College of Medicine.

On Sunday, July 31st Donna Arnett, MSPH, PhD will be honored with the Joseph Stokes III, MD Award, presenting "Personalization of Individual Prevention Strategies for Hypertension - Applying '-omics'". Dr. Arnett is Dean of the University of Kentucky College of Public Health and a Professor in the Department of Epidemiology.

The ASPC encourages all to join the world-renowned faculty presenting across the spectrum of preventive cardiology at #ASPC2022 including lectures on cholesterol management for primary CVD prevention, tobacco cessation, barriers associated with the treatment of diabetes, treating obesity as a CV risk factor, open artery ischemia, the role of stress management on CVD, the cardio-renal-metabolic intersection, and an exciting debate about aspirin's role in primary prevention.

Attendees of the 2022 Congress will earn approximately 15 CE/MOC/AAPA credits.

For more information: https://www.aspconline.org/


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now